TrialLineage Concept
Extracellular matrix
The extracellular matrix (ECM) is the network of proteins, glycoproteins, and other molecules that surrounds and supports cells in tissues. In fibrotic diseases, excessive ECM deposition by activated fibroblasts replaces functional tissue with dense scar tissue.
What is the extracellular matrix?
The ECM is not simply inert scaffolding. It is a dynamic, constantly remodeled structure that provides mechanical support, regulates cell behavior, stores growth factors, and transmits signals. Its major structural components include collagens (providing tensile strength), elastin (providing elasticity), fibronectin (mediating cell adhesion), and proteoglycans (retaining water and regulating signaling).
In healthy tissues, ECM production and degradation are balanced. Matrix metalloproteinases (MMPs) break down old matrix while fibroblasts produce new matrix as needed. In fibrotic disease, this balance shifts toward excessive production — fibroblasts deposit matrix faster than it can be remodeled, leading to progressive stiffening and loss of organ function.
Connection to the IPF lineage
In IPF, excessive ECM deposition in the lung interstitium is what physically destroys lung architecture and gas exchange capacity. The fibrotic scar tissue is primarily composed of ECM. Therapies targeting fibrosis — including LPA1 antagonism — aim to reduce the upstream signaling that drives fibroblasts to overproduce this matrix.